Vinblastine

CHEMBL159 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
811.0 g/mol
LogP
3.7
Phase
4

This chemotherapy drug derived from the periwinkle plant (Vinca rosea) is used to treat cancers including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, bladder cancer, and breast cancer. It works by interfering with the formation of the mitotic spindle, a structure cancer cells need to divide and multiply. It can cause peripheral neuropathy (tingling and numbness in hands and feet) and must not be given by spinal injection as this is fatal.

分子量

811.0000 g/mol

LogP

3.70

TPSA

154.00 Ų

Lipinski 五规则

不符合

治疗领域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1

InChI

InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1

Molecular Formula

C46H58N4O9

HBD / HBA

3 / 12

可旋转键数

10

重原子数

59

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

This chemotherapy drug derived from the periwinkle plant (Vinca rosea) is used to treat cancers including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, bladder cancer, and breast cancer. It works by interfering with the formation of the mitotic spindle, a structure cancer cells need to divide and multiply. It can cause peripheral neuropathy (tingling and numbness in hands and feet) and must not be given by spinal injection as this is fatal.

Yes, Vinblastine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL159. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 13342. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.